Gain Therapeutics (GANX) Asset Utilization Ratio (2021 - 2023)

Gain Therapeutics' Asset Utilization Ratio history runs 3 years deep, the most recent figure standing at 0.0 for Q4 2023.

• In Q4 2023, Asset Utilization Ratio fell 33.32% year-over-year to 0.0; the TTM figure through Dec 2023 stood at 0.0 (down 33.32% YoY), while the FY2023 annual figure was 0.0, down 38.55% from the prior year.
• Asset Utilization Ratio for Q4 2023 stood at 0.0, up from 0.0 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.01 in Q1 2023, with the low at 0.0 in Q1 2021.
• The 3-year median for Asset Utilization Ratio is 0.0 (2021), against an average of 0.0.
• The sharpest annual moves came in 2022 and 2023: Asset Utilization Ratio surged 340.61% in 2022, then slumped 53.36% in 2023.
• Gain Therapeutics' Asset Utilization Ratio stood at 0.0 in 2021, then surged by 70.37% to 0.01 in 2022, then sank by 33.32% to 0.0 in 2023.
• Business Quant data shows GANX's Asset Utilization Ratio at 0.0 in Q4 2023, 0.0 in Q3 2023, and 0.0 in Q2 2023.